Tendinopathy
Conditions
Keywords
pain, range of motion, quality of life
Brief summary
Tendinopathy is an inflammatory process that occurs in and around the tendon when both are affected by a certain injury. In the case of the supraspinatus muscle it is one of the most frequent causes of shoulder pain. To test the efficacy of laser treatment in reducing shoulder pain caused by supraspinatus muscle tendinopathy. A randomized controlled clinical trial (RCT) was carried out in which a physiotherapy intervention was performed using therapeutic laser for three months, to observe the influence on the pain generated by supraspinatus muscle tendinopathy in the shoulder.
Interventions
DEVICEPlacebo Group
A placebo treatment is carried out on the shoulder, simulating the application of the laser.
DEVICELaser Group
Therapeutic laser treatment is performed on the shoulder.
Sponsors
Universidad Pontificia de Salamanca
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)
Masking description
triple blinding
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Score of 3 or higher on the VAS scale for the shoulder. * Adequate cognitive ability for comprehension. * Rotator cuff tendinopathy confirmed by ultrasound at the study center, either due to tendon inflammation, presence of hypoechoic areas, calcification, fibrillar disorganization, and/or neovascularization in the supraspinatus muscle. * Pain in the proximal lateral part of the arm that worsens with abduction.
Exclusion criteria
* Contraindications specific to laser treatment (e.g., tumors, presence of pacemaker or defibrillator, pregnancy, etc.). * History of glenohumeral fracture and rheumatoid arthritis. * Rheumatic, neurological, or structural polymyalgia affecting the joint. * Previous surgeries. * Pregnant or breastfeeding women. * Taking anticoagulants or antiplatelet agents. * Diabetes mellitus. * Cardiac dysfunction. * Infiltrative and/or rehabilitative treatment in the two months prior to recruitment. * Pre-existing conditions associated with pain in the upper extremities. Difficulties with follow-up. * Depression. * Treatment with another intervention; during the study, they will not be able to undergo it.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| intensity of pain. | 3 months | measured using the VAS scale, where 0 is the least possible pain and 10 is the greatest possible pain |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Range of motion | 3 months | Shoulder mobility in the joint ranges of flexion, extension, abduction, adduction, and external and internal rotation. Measurement in degrees using a goniometer. |
| Patient quality of life | 3 months | DASH questionnaire The score ranges from 0, which is equivalent to having no disability, to a maximum of 100, which is equivalent to having a very severe functional limitation. |
Countries
Spain
Outcome results
None listed